SCHEDULE 13G
SCHEDULE 13GSchedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares · CUSIP: 589492107
Event date: 2025-04-01
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 27,578,325.00 · Class: 3.5%
- FHMLSP, L.P.
Shares: 27,578,325.00 · Class: 3.5%
- FHMLSP, L.L.C.
Shares: 27,578,325.00 · Class: 3.5%
- Frazier Life Sciences Public Overage Fund, L.P.
Shares: 7,509,280.00 · Class: 0.9%
- FHMLSP Overage, L.P.
Shares: 7,509,280.00 · Class: 0.9%
- FHMLSP Overage, L.L.C.
Shares: 7,509,280.00 · Class: 0.9%
- Frazier Life Sciences X, L.P.
Shares: 1,590,155.00 · Class: 0.2%
- FHMLS X, L.P.
Shares: 1,590,155.00 · Class: 0.2%
- FHMLS X, L.L.C.
Shares: 1,590,155.00 · Class: 0.2%
- Frazier Life Sciences XI, L.P.
Shares: 3,671,555.00 · Class: 0.5%
- FHMLS XI, L.P.
Shares: 3,671,555.00 · Class: 0.5%
- FHMLS XI, L.L.C.
Shares: 3,671,555.00 · Class: 0.5%
- James N. Topper
Shares: 40,349,315.00 · Class: 5.1%
- Patrick J. Heron
Shares: 40,349,315.00 · Class: 5.1%
- Albert Cha
Shares: 35,087,605.00 · Class: 4.4%
- James Brush
Shares: 35,087,605.00 · Class: 4.4%
- Daniel Estes
Shares: 3,671,555.00 · Class: 0.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-010152
- Form type
- SCHEDULE 13G
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Apr 04, 2025
- Reporting period
- Apr 01, 2025
- Description
- Schedule 13G beneficial ownership